# Nemedio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nemedio

- Industry: Software
- Headquarters: New York, US
- Website: www.nemedio.com
- Total disclosed funding: $2.5M
- Latest round: Seed (Jun 24, 2019)
- Investors on record: 5

## About

Based in New York, US, and founded in 2017, Nemedio Inc. operates as a developer of solutions to accelerate the development of medical devices and technologies throughout every stage of the product development cycle, including regulatory checks, compliance achievement, and ongoing post-market compliance maintenance. The company was founded by its CEO, Sabrina Varanelli. In June 2023, Nemedio Inc. raised USD 750,000 in venture funding.

The company offers a range of operations management services that adhere to compliance standards. These services include starter compliance, basic compliance, setting up a quality management system (QMS), quality engineering and development support, postmarket compliance support, and tooling. Its platform provides technology solutions tailored for the medical device community, intending to reduce risks and streamline the development process for medical devices. By utilizing the software development kit, clients can generate a compliant development framework that integrates with the medically certified QNX operating system, empowering them to expedite the advancement of medical technologies.

## Funding rounds

- Seed, Jun 24, 2019, $2.5M — Eniac Ventures, Notation, Charge Ventures, Story Ventures, Supernode Ventures

## Investors

- Eniac Ventures (https://capitalatlas.ai/funds/eniac-ventures) — Seed
- Notation (https://capitalatlas.ai/funds/notation) — Seed
- Charge Ventures (https://capitalatlas.ai/funds/charge-ventures) — Seed
- Story Ventures (https://capitalatlas.ai/funds/story-ventures) — Seed
- Supernode Ventures (https://capitalatlas.ai/funds/supernode-ventures) — Seed